Bayer invests USD 50 Million in eGenesis Series B financing round
Series B Investment
in eGenesis Bio
US$50,000,000
We use analytics cookies to help us understand how users interact with our sites, such as identifying the most popular content. If you accept these cookies, it will help us improve our content and user experiences.AcceptReject
